Engineering live bacterial therapeutics to treat human diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Engineering live bacterial therapeutics to treat human diseases

Published:2024-03 Issue: Volume:37 Page:100492
ISSN:2452-3100
Container-title:Current Opinion in Systems Biology
language:en
Short-container-title:Current Opinion in Systems Biology

Author:

Hwang In Young^ORCID

Funder

Asian Office of Aerospace Research and Development

National Research Foundation Singapore

Ministry of Defence, Singapore

Publisher

Elsevier BV

Subject

Applied Mathematics,Computer Science Applications,Drug Discovery,General Biochemistry, Genetics and Molecular Biology,Modeling and Simulation

Reference42 articles.

1. Programmable probiotics for detection of cancer in urine;Danino;Sci Transl Med,2015

2. Programmable bacteria induce durable tumor regression and systemic antitumor immunity;Chowdhury;Nat Med,2019

3. Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies;Gurbatri;Sci Transl Med,2020

4. Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity;Leventhal;Nat Commun,2020

5. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy;He;J Biol Eng,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP